Search Results - Heiko Schoder
- Showing 1 - 20 results of 28
- Go to Next Page
-
1
-
2
-
3
Machine-learning based quantification of lung shunt fraction from 99mTc-MAA SPECT/CT for selective internal radiation therapy of liver tumors using TriDFusion (3DF) by Daniel Lafontaine, Finn Augensen, Adam Kesner, Raoul Vincent, Assen Kirov, Simone Krebs, Heiko Schöder, John L. Humm
Published in EJNMMI Physics (2025-03-01)Get full text
Article -
4
TriDFusion (3DF) image viewer by Daniel Lafontaine, C. Ross Schmidtlein, Assen Kirov, Ryan P. Reddy, Simone Krebs, Heiko Schöder, John L. Humm
Published in EJNMMI Physics (2022-10-01)Get full text
Article -
5
-
6
-
7
Predicting the hypoxic volume of head and neck tumors from fluorodeoxyglucose positron emission tomography images using artificial intelligence by Wei Zhao, Milan Grkovski, Heiko Schoder, Aditya P. Apte, John Humm, Nancy Y. Lee, Joseph O. Deasy, Harini Veeraraghavan
Published in Physics and Imaging in Radiation Oncology (2025-04-01)Get full text
Article -
8
Brown adipose tissue machine learning nnU-Net V2 network using TriDFusion (3DF) by Daniel Lafontaine, Stephanie Chahwan, Gustavo Barraza, Burcin Agridag Ucpinar, Gunjan Kayal, Nicolás Gómez-Banoy, Paul Cohen, John L. Humm, Heiko Schöder
Published in EJNMMI Research (2025-08-01)Get full text
Article -
9
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis by Sungmin Woo, Soleen Ghafoor, Anton S. Becker, Sangwon Han, Andreas G. Wibmer, Hedvig Hricak, Irene A. Burger, Heiko Schöder, Hebert Alberto Vargas
Published in European Journal of Hybrid Imaging (2020-09-01)Get full text
Article -
10
Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic... by Sangwon Han, Sungmin Woo, Yong-il Kim, Jae-Lyun Lee, Andreas G. Wibmer, Heiko Schoder, Jin-Sook Ryu, Hebert Alberto Vargas
Published in Diagnostics (2021-04-01)Get full text
Article -
11
Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy by Aurélien Marabelle, Samy Ammari, Eric Deutsch, Michael Farwell, Heiko Schöder, Lawrence H Schwartz, Binsheng Zhao, Laurent Dercle, Jeremy McGale, Shawn Sun, Randy Yeh, Fatima-Zohra Mokrane
Published in Journal for ImmunoTherapy of Cancer (2022-09-01)Get full text
Article -
12
Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations by Philipp Berning, Adrian E. Schroer, Rishav Adhikari, Alexander C. Razavi, Francois H. Cornelis, Joseph P. Erinjeri, Stephen B. Solomon, Debkumar Sarkar, Hebert Alberto Vargas, Heiko Schöder, Josef J. Fox, Omar Dzaye, Omar Dzaye
Published in Frontiers in Oncology (2024-02-01)Get full text
Article -
13
Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis by Pallawi Torka, Levi D. Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl, Howard R. Higley, Gary Kelloff, Jonathan W. Friedberg, Lawrence H. Schwartz, Wyndham H. Wilson, John P. Leonard, Nancy L. Bartlett, Heiko Schöder, Amy S. Ruppert
Published in Cancer Medicine (2023-04-01)Get full text
Article -
14
P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie... by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Massimo Federico, Gunilla Enblad, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella
Published in HemaSphere (2022-10-01)Get full text
Article -
15
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Stefano Luminari, Daniel Molin, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella
Published in Blood Cancer Journal (2025-10-01)Get full text
Article -
16
[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer by Philipp Backhaus, Keith S. Pentlow, Alan L Ho, Audrey Mauguen, James A Fagin, Naga Vara Kishore Pillarsetty, Serge K. Lyashchenko, Eva Burnazi, Ronald A. Ghossein, Shalini Chhabra, Murad Abusamra, Steven M. Larson, Heiko Schöder, Joseph O’Donoghue, Wolfgang Weber, Ravinder K. Grewal
Published in EJNMMI Research (2024-10-01)Get full text
Article -
17
P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Ind... by Julia Driessen, Fer De Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. Lacasce, Peter D. Cole, Craig H. Moskowitz, Ramón. García Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée. M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Published in HemaSphere (2022-10-01)Get full text
Article -
18
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes by Paola Ghione, Salma Ahsanuddin, Efrat Luttwak, Sabela Bobillo Varela, Reiko Nakajima, Laure Michaud, Kanika Gupta, Anastasia Navitski, David Straus, M. Lia Palomba, Alison Moskowitz, Ariela Noy, Paul Hamlin, Matthew Matasar, Anita Kumar, Lorenzo Falchi, Joachim Yahalom, Steven Horwitz, Andrew Zelenetz, Anas Younes, Gilles Salles, Heiko Schöder, Erel Joffe
Published in Haematologica (2023-08-01)Get full text
Article -
19
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes by Yannis K. Valtis, Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna De Abia, Alfredo Rivas-Delgado, Efrat Luttwak, Giulio Cassanello, Ivan Landego, Heiko Schöder, Akshay Bedmutha, Alexander Boardman, Gunjan L. Shah, Michael Scordo, Miguel-Angel Perales, Gilles Salles, M. Lia Palomba, Urvi A. Shah, Jae H. Park
Published in Blood Advances (2025-01-01)Get full text
Article -
20
<i>Erratum</i> to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation by Zachary D. Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Ahmet Dogan, Pamela Drullinsky, John Gerecitano, Paul A. Hamlin, Caleb Ho, Allison Jacob, Ashlee Joseph, Leana Laraque, Matthew J. Matasar, Alison J. Moskowitz, Craig H. Moskowitz, Chelsea Mullins, Colette Owens, Gilles Salles, Heiko Schöder, David J. Straus, Anas Younes, Andrew D. Zelenetz, Anita Kumar
Published in Haematologica (2024-08-01)Get full text
Article
